DSpace Repository

Progress in discovery and development of natural inhibitors of histone deacetylases (HDACs) as anti-cancer agents

Show simple item record

dc.contributor.author Jadhav, Hemant R.
dc.date.accessioned 2023-12-01T07:14:40Z
dc.date.available 2023-12-01T07:14:40Z
dc.date.issued 2023-08
dc.identifier.uri https://link.springer.com/article/10.1007/s00210-023-02674-4
dc.identifier.uri http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13301
dc.description.abstract The study of epigenetic translational modifications had drawn great interest for the last few decades. These processes play a vital role in many diseases and cancer is one of them. Histone acetyltransferase (HAT) and histone deacetylases (HDACs) are key enzymes involved in the acetylation and deacetylation of histones and ultimately in post-translational modifications. Cancer frequently exhibits epigenetic changes, particularly disruption in the expression and activity of HDACs. It includes the capacity to regulate proliferative signalling, circumvent growth inhibitors, escape cell death, enable replicative immortality, promote angiogenesis, stimulate invasion and metastasis, prevent immunological destruction, and genomic instability. The majority of tumours develop and spread as a result of HDAC dysregulation. As a result, HDAC inhibitors (HDACis) were developed, and they today stand as a very promising therapeutic approach. One of the most well-known and efficient therapies for practically all cancer types is chemotherapy. However, the efficiency and safety of treatment are constrained by higher toxicity. The same has been observed with the synthetic HDACi. Natural products, owing to many advantages over synthetic compounds for cancer treatment have always been a choice for therapy. Hence, naturally available molecules are of particular interest for HDAC inhibition and HDAC has drawn the attention of the research fraternity due to their potential to offer a diverse array of chemical structures and bioactive compounds. This diversity opens up new avenues for exploring less toxic HDAC inhibitors to reduce side effects associated with conventional synthetic inhibitors. The review presents comprehensive details on natural product HDACi, their mechanism of action and their biological effects. Moreover, this review provides a brief discussion on the structure activity relationship of selected natural HDAC inhibitors and their analogues which can guide future research to discover selective, more potent HDACi with minimal toxicity. en_US
dc.language.iso en en_US
dc.publisher Springer en_US
dc.subject Pharmacy en_US
dc.subject Histone acetyltransferase (HAT) en_US
dc.subject Histone deacetylases (HDACs) en_US
dc.subject HDAC inhibitors (HDACis) en_US
dc.title Progress in discovery and development of natural inhibitors of histone deacetylases (HDACs) as anti-cancer agents en_US
dc.type Article en_US


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account